Anti-inflammatory effects of probiotic Lactobacillus casei strain Shirota in chronic intestinal inflammatory disorders

International Journal of Probiotics and Prebiotics

Volumn 3, Issue 3, 2008, Pages 149-152

  Matsumoto, Satoshi ^a  

^a YAKULT CENTRAL INSTITUTE FOR MICROBIOLOGICAL RESEARCH   (Japan)

Author keywords

Colitis; IBD; Inflammatory bowel disease; Mucosal immunity

Indexed keywords

EID: 79952208518     PISSN: 15551431     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (19)

1. Alonzi T., Fattori E., Lazzaro D., Costa P., Probert L., Kollias G., Benedetti F., Poli V. And Ciliberto G. (1998) Interleukin 6 is required for the development of collagen-induced arthritis. The Journal of Experimental Medicine 187, 461-468.
2. Aoe T., Okamoto Y. and Saito T. (1995) Activated macrophages induce structural abnormalities of the T cell receptor-CD3 complex. The Journal of Experimental Medicine 181, 1881-1889.
3. Aso Y., Akaza H., Kotake T., Tsukamoto T., Imai K. and Naito S. (1995) Preventive effect of Lactobacillus casei preparation on the recurrence of superficial bladder cancer in a double-blind trial. The BLP Study Group. European Urology 27, 104-109.
4. Cooper H.S., Murthy S.N., Shah R.S. and Sedergran D.J. (1993) Clinicopathologic study of dextran sulfate sodium experimental murine colitis. Laboratory Investigation 69, 238-249.
5. Duchmann R., Kaiser I., Herhann E., Mayer W., Ewe K. and Mayer zum Buschenfelde KH. (1995) Tolerance exists towards resident intestinal flora but is broken in active inflammatory bowel disease. Clinical and Experimental Immunology 102, 448-455.
6. Gionchetti P., Rizzello F., Venturi A., Brigidi P., Matteuzzi D., Bazzochi G., Poggioli G., Miglioli M. and Campieri M. (2000) Oral bacteriotherapy as maintenance treatment in patients with chronic pouchitis: a double-blind, placebo-controlled trial. Gastroenterology 119, 305-309.
7. Hori T., Kiyoshima J., Shida K. and Yasui H. (2002) Augmentation of cellular immunity and reduction of influenza virus titer in aged mice fed Lactobacillus casei strain Shirota. Clinical and Diagnostic Laboratory Immunology 9, 105-108.
8. Kato I., Endo-Tanaka K. and Yokokura T. (1998) Suppressive effects of the oral administration of Lactobacillus casei on type II collagen-induced arthritis in DBA/1 mice. Life Sciences 63, 635-644.
9. Madsen K.L., Doyle J.S., Jewell L.D., Tavernini M.M. and Fedorak R.N. (1999) Lactobacillus species prevents colitis in interleukin-10 gene-deficient mice. Gastroenterology 116, 1107-1114.
10. Matsumoto S., Watanabe N. and Umesaki Y, (2000) Roles of chloroform-resistant variants in mouse models of experimental colitis. Microbial Ecology in Health and Disease 12, 102-108.
11. Matsumoto S., Watanabe N., Imaoka A. and Okabe Y. (2001) Preventive effects of Bifidobacterium-and Lactobacillus-fermented milk on the development of inflammatory bowel disease in senescence-accelerated mouse (SAM) P1/Yit strain mice. Digestion 64, 92-99.
12. Matsumoto S., Hara T., Hori T., Mitsuyama K., Nagaoka M., Tomiyasu N., Suzuki A. and Sata M. (2005) Probiotic Lactobacillus-induced improvement in murine chronic inflammatory bowel disease is associated with the down-regulation of pro-inflammatory cytokines in lamina propria mononuclear cells. Clinical and Experimental Immunology 140, 417-426.
13. Matsuzaki T, Nagata Y, Kado S., Uchida K., Kato I., Hashimoto S. and Yokokura T. (1997) Prevention of onset in an insulin-dependent diabetes mellitus model, NOD mice, by oral feeding of Lactobacillus casei. Acta Pathologica, Microbiologica et Immunologica Scandinavica 105, 643-649.
14. Mike A., Nagaoka N., Tagami Y., Miyashita M., Shimada S., Uchida K., Nanno M, and Ohwaki M. (1999) Prevention of B220+ T cell expansion and prolongation of lifespan induced by Lactbacillus casei in MRL/lpr mice. Clinical and Experimental Immunology 117, 357-68.
15. Nanno M, Shimizu-Takeda T, Mike A, Ohwaki M, Togashi Y, Suzuki R, Kumagai K. and Mutai M. (1989) Increased production of cytolytic macrophage progenitors by Lactobacillus casei in mice. Journal of Leukocyte Biology 46, 89-95.
16. Ohshima S., Saeki Y., Mima T., Sasaki M., Nishioka K., Nomura S., Kopf M., Katada Y., Tanaka T., Suemura M. and Kishimoto T. (1998) Interleukin 6 plays a key role in the development of antigen-induced arthritis. Proceedings of the National Academy of Sciences of the USA 95, 8222-8226.
17. Rogler G. and Andus T. (1998) Cytokines in inflammatory bowel disease. World Journal of Surgery 22, 382-389.
18. Sadlack B., Merz H., Schorle H., Schimpl A., Feller AC. and Horak I. (1993) Ulcerative colitis-like disease in mice with disrupted interleukin-2 gene. Cell 75, 253-261.
19. Yamamoto M., Yoshizaki K., Kishimoto T. and Ito H. (2000) IL6 is required for the development of Th1 cell mediated murine colitis. Journal of Immunology 164, 4878-4882.